These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
406 related articles for article (PubMed ID: 31918714)
1. Tumor- and mitochondria-targeted nanoparticles eradicate drug resistant lung cancer through mitochondrial pathway of apoptosis. Wang H; Zhang F; Wen H; Shi W; Huang Q; Huang Y; Xie J; Li P; Chen J; Qin L; Zhou Y J Nanobiotechnology; 2020 Jan; 18(1):8. PubMed ID: 31918714 [TBL] [Abstract][Full Text] [Related]
2. pH-activated, mitochondria-targeted, and redox-responsive delivery of paclitaxel nanomicelles to overcome drug resistance and suppress metastasis in lung cancer. Wang H; Shi W; Zeng D; Huang Q; Xie J; Wen H; Li J; Yu X; Qin L; Zhou Y J Nanobiotechnology; 2021 May; 19(1):152. PubMed ID: 34022909 [TBL] [Abstract][Full Text] [Related]
3. Aminoglucose-functionalized, redox-responsive polymer nanomicelles for overcoming chemoresistance in lung cancer cells. Zhou Y; Wen H; Gu L; Fu J; Guo J; Du L; Zhou X; Yu X; Huang Y; Wang H J Nanobiotechnology; 2017 Nov; 15(1):87. PubMed ID: 29179722 [TBL] [Abstract][Full Text] [Related]
4. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer. Liu HN; Guo NN; Guo WW; Huang-Fu MY; Vakili MR; Chen JJ; Xu WH; Wei QC; Han M; Lavasanifar A; Gao JQ Acta Pharmacol Sin; 2018 Oct; 39(10):1681-1692. PubMed ID: 29849132 [TBL] [Abstract][Full Text] [Related]
5. Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment. Song Y; Cai H; Yin T; Huo M; Ma P; Zhou J; Lai W Int J Nanomedicine; 2018; 13():1585-1600. PubMed ID: 29588586 [TBL] [Abstract][Full Text] [Related]
6. Overcoming drug-resistant lung cancer by paclitaxel-loaded hyaluronic acid-coated liposomes targeted to mitochondria. Tian Y; Zhang H; Qin Y; Li D; Liu Y; Wang H; Gan L Drug Dev Ind Pharm; 2018 Dec; 44(12):2071-2082. PubMed ID: 30112929 [TBL] [Abstract][Full Text] [Related]
7. Redox-responsive F127-folate/F127-disulfide bond-d-α-tocopheryl polyethylene glycol 1000 succinate/P123 mixed micelles loaded with paclitaxel for the reversal of multidrug resistance in tumors. Lin J; Zhao C; Liu C; Fu S; Han L; Lu X; Yang C Int J Nanomedicine; 2018; 13():805-830. PubMed ID: 29445276 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial targeting nanodrugs self-assembled from 9-O-octadecyl substituted berberine derivative for cancer treatment by inducing mitochondrial apoptosis pathways. Song J; Lin C; Yang X; Xie Y; Hu P; Li H; Zhu W; Hu H J Control Release; 2019 Jan; 294():27-42. PubMed ID: 30445003 [TBL] [Abstract][Full Text] [Related]
9. Nanoparticle-Mediated Mitochondrial Damage Induces Apoptosis in Cancer. Mallick A; More P; Syed MM; Basu S ACS Appl Mater Interfaces; 2016 Jun; 8(21):13218-31. PubMed ID: 27160664 [TBL] [Abstract][Full Text] [Related]
10. Mitochondrial Targeted Doxorubicin-Triphenylphosphonium Delivered by Hyaluronic Acid Modified and pH Responsive Nanocarriers to Breast Tumor: in Vitro and in Vivo Studies. Liu HN; Guo NN; Wang TT; Guo WW; Lin MT; Huang-Fu MY; Vakili MR; Xu WH; Chen JJ; Wei QC; Han M; Lavasanifar A; Gao JQ Mol Pharm; 2018 Mar; 15(3):882-891. PubMed ID: 29357260 [TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid-modified selenium nanoparticles for enhancing the therapeutic efficacy of paclitaxel in lung cancer therapy. Zou J; Su S; Chen Z; Liang F; Zeng Y; Cen W; Zhang X; Xia Y; Huang D Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3456-3464. PubMed ID: 31469318 [TBL] [Abstract][Full Text] [Related]
12. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion. Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386 [TBL] [Abstract][Full Text] [Related]
13. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer. Wang F; Li L; Liu B; Chen Z; Li C Biomed Pharmacother; 2017 Feb; 86():595-604. PubMed ID: 28027535 [TBL] [Abstract][Full Text] [Related]
14. Investigation on vitamin e succinate based intelligent hyaluronic acid micelles for overcoming drug resistance and enhancing anticancer efficacy. Hou L; Tian C; Chen D; Yuan Y; Yan Y; Huang Q; Zhang H; Zhang Z Eur J Pharm Sci; 2019 Dec; 140():105071. PubMed ID: 31525433 [TBL] [Abstract][Full Text] [Related]
15. A novel paclitaxel-loaded poly(d,l-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment. Yuan X; Ji W; Chen S; Bao Y; Tan S; Lu S; Wu K; Chu Q Int J Nanomedicine; 2016; 11():2119-31. PubMed ID: 27307727 [TBL] [Abstract][Full Text] [Related]
16. The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery. Yao HJ; Ju RJ; Wang XX; Zhang Y; Li RJ; Yu Y; Zhang L; Lu WL Biomaterials; 2011 Apr; 32(12):3285-302. PubMed ID: 21306774 [TBL] [Abstract][Full Text] [Related]
17. The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer. Zhou J; Zhao WY; Ma X; Ju RJ; Li XY; Li N; Sun MG; Shi JF; Zhang CX; Lu WL Biomaterials; 2013 May; 34(14):3626-38. PubMed ID: 23422592 [TBL] [Abstract][Full Text] [Related]
18. Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor. Chen Y; Zhang W; Huang Y; Gao F; Sha X; Fang X Int J Pharm; 2015 Jul; 488(1-2):44-58. PubMed ID: 25899286 [TBL] [Abstract][Full Text] [Related]
19. Hyaluronic Acid-Targeted Stimuli-Sensitive Nanomicelles Co-Encapsulating Paclitaxel and Ritonavir to Overcome Multi-Drug Resistance in Metastatic Breast Cancer and Triple-Negative Breast Cancer Cells. Gote V; Sharma AD; Pal D Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513992 [TBL] [Abstract][Full Text] [Related]
20. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response. Jiang L; Li L; He X; Yi Q; He B; Cao J; Pan W; Gu Z Biomaterials; 2015 Jun; 52():126-39. PubMed ID: 25818419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]